Outset Medical Inc expected to post a loss of 61 cents a share - Earnings Preview

Outset Medical

19/02/2024 23:13

* Outset Medical Inc  OM.OQ   OM.O  is expected to show a
fall in
quarterly revenue when it reports  results on February 21 for
the period ending December 31 2023
    * The San Jose California-based  company is expected to
report a
5.0% decrease in revenue to $30.404 million from $32.01 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Outset Medical Inc is
for a
loss of 61 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Outset
Medical
Inc is $6.00​, above​ its last closing price of $3.41. ​​​

The company's guidance on November 7 2023 for the period ended
December 31 was for gross profit margin between 20.4% and 20.6%.
Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.67       -0.67      -0.71     Missed  -6.5
 Jun. 30 2023  -0.84       -0.76      -0.90     Missed  -18
 Mar. 31 2023  -0.78       -0.74      -0.90     Missed  -21.3​
 Dec. 31 2022  -0.91       -0.86      -0.86     Met     0
 ​​Sep.        -0.84       -0.81      -0.85     Missed  -4.9
 30 2022                                                
 Jun. 30 2022  -0.68       -0.70      -0.92     Missed  -31.8​
 Mar. 31 2022  -0.71       -0.72      -0.78     Missed  -8.3
 Dec. 31 2021  -0.75       -0.77      -0.87     Missed  -13.4
 This summary was machine generated February 19 at 23:13 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)